Form 4: Nanophase Technologies CEO Jess Jankowski Reports Stock Option Grant

Sentiment:

SEC Form 4 Filing


Nanophase Technologies CEO Jess Jankowski reports the acquisition of 22,500 stock options and indirect ownership of 1,000 shares through a spouse's IRA.

Delay expectedThe Form 4 filing was submitted late due to an administrative error by the company.

Summary

  • Jess Jankowski, CEO of Nanophase Technologies, filed a Form 4 disclosing changes in beneficial ownership.
  • The filing reports the acquisition of 22,500 stock options at an exercise price of $2.44, vesting in three equal annual installments starting December 31, 2025.
  • Jankowski also reported indirect ownership of 1,000 common stock shares through a spouse's IRA.
  • The filing also details existing stock options held by Jankowski, with various exercise prices and expiration dates.
  • The report was filed late due to an administrative error by the company.

Sentiment

Score: 7

Explanation: The document is neutral to slightly positive. The stock option grant is a standard practice, but the late filing due to an administrative error is a minor negative.

Positives

  • The grant of stock options to the CEO aligns his interests with those of shareholders.
  • The vesting schedule of the options encourages long-term performance.

Negatives

  • The Form 4 filing was submitted late due to an administrative error by the company.

Risks

  • Administrative errors in filings can raise concerns about internal controls.
  • The value of the stock options is dependent on the future performance of the company's stock price.

Future Outlook

The stock options vest over three years, incentivizing long-term performance.

Management Comments

  • Mr. Jankowski received this grant of stock options as part of the Company's annual equity compensation practices.

Industry Context

Stock option grants are a common form of executive compensation in publicly traded companies, aligning management's interests with those of shareholders.

Comparison to Industry Standards

  • Stock option grants are a standard practice for executive compensation across various industries.
  • The vesting schedule of three years is also a common practice to encourage long-term value creation.
  • The exercise prices of the options are based on the market value of the stock at the time of the grant, which is typical.

Stakeholder Impact

  • The stock option grant aligns the CEO's interests with those of shareholders.
  • The late filing may raise minor concerns among shareholders about internal controls.

Key Dates

DateDescription
02/23/2017Start date for vesting of stock options with an exercise price of $0.42.
02/21/2018Start date for vesting of stock options with an exercise price of $0.68.
05/23/2019Start date for vesting of stock options with an exercise price of $0.82.
05/22/2020Start date for vesting of stock options with an exercise price of $0.51.
06/18/2021Start date for vesting of stock options with an exercise price of $0.45.
12/28/2022Start date for vesting of stock options with an exercise price of $4.17.
12/20/2023Start date for vesting of stock options with an exercise price of $1.165.
12/27/2024Start date for vesting of stock options with an exercise price of $0.61.
12/31/2024Date of the reported transaction and grant of 22,500 stock options at $2.44.
12/31/2025Start date for vesting of the 22,500 stock options granted on 12/31/2024.
01/13/2025Date the Form 4 was signed.

Keywords

stock options, Form 4, beneficial ownership, executive compensation, Nanophase Technologies, Jess Jankowski, equity, securities

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.